Fibroblast Growth Factor 21 Ameliorates NaV1.5 and Kir2.1 Channel Dysregulation in Human AC16 Cardiomyocytes.

Infarcted myocardium is predisposed to cause lethal ventricular arrhythmias that remain the main cause of death in patients suffering myocardial ischemia. Liver-derived fibroblast growth factor 21 (FGF21) is an endocrine regulator, which exerts metabolic actions by favoring glucose and lipids metabolism. Emerging evidence has shown a beneficial effect of FGF21 on cardiovascular diseases, but the role of FGF21 on ventricular arrhythmias following myocardial infarction (MI) in humans has never been addressed. This study was conducted to investigate the pharmacological effects of FGF21 on cardiomyocytes after MI in humans. Patients with arrhythmia in acute MI and healthy volunteers were enrolled in this study. Serum samples were collected from these subjects on day 1 and days 7-10 after the onset of MI for measuring FGF21 levels using ELISA. Here, we found that the serum level of FGF21 was significantly increased on day 1 after the onset of MI and it returned to normal on days 7-10, relative to the Control samples. In order to clarify the regulation of FGF21 on arrhythmia, two kinds of arrhythmia animal models were established in this study, including ischemic arrhythmia model (MI rat model) and nonischemic arrhythmia model (ouabain-induced guinea pig arrhythmia model). The results showed that the incidence and duration time of ischemic arrhythmias in rhbFGF21-treated MI rats were significantly reduced at different time point after MI compared with normal saline-treated MI rats. Moreover, the onset of the first ventricular arrhythmias was delayed and the numbers of VF and maintenance were attenuated by FGF21 compared to the rhbFGF21-untreated group in the ouabain model. Consistently, in vitro study also demonstrated that FGF21 administration was able to shorten action potential duration (APD) in hydrogen peroxide-treated AC16 cells. Mechanically, FGF21 can ameliorate the electrophysiological function of AC16 cells, which is characterized by rescuing the expression and dysfunction of cardiac sodium current (I Na) and inward rectifier potassium (I k1) in AC16 cells induced by hydrogen peroxide. Moreover, the restorative effect of FGF21 on NaV1.5 and Kir2.1 was eliminated when FGF receptors were inhibited. Collectively, FGF21 has the potential role of ameliorating transmembrane ion channels remodeling through the NaV1.5/Kir2.1 pathway by FGF receptors and thus reducing life-threatening postinfarcted arrhythmias, which provides new strategies for antiarrhythmic therapy in clinics.

Arbuscular mycorrhizal fungus-mediated amelioration of NO2-induced phytotoxicity in tomato.

Atmospheric nitrogen dioxide (NO2) negatively affects plant (crop) growth and development, as well the yield and quality in some regions or environments. Arbuscular mycorrhizal fungus (AMF)-mediated amelioration of NO2-induced plant damage has been reported, but the underlying mechanisms remained unclear. This study explored the beneficial effect of AMF symbiosis on tomato plant responses to NO2 at physiology, biochemistry, and gene expression, with an emphasis on nitrate metabolism, antioxidative defense, and photosynthetic performance. Pot-grown plants were used in the experiments, which were performed in laboratory from February to November 2019. NO2 fumigation with a dose of 10 ± 1 ppm was carried out after 50 d of plant growth, and data were collected following 8 h of fumigation. NO2 fumigation (+NO2) and AMF inoculation (+AMF), alone and especially in combination (NO2 + AMF), increased the gene expression of nitrate- and nitrite reductase, and their enzymatic activity in leaves, such as by 61%, 27%, and 126% for the activity of nitrate reductase, and by 95%, 37%, and 188% for nitrite reductase, respectively, in +NO2, +AMF, and AMF + NO2 plants relative the control (-NO2, -AMF) levels. Following NO2 exposure, +AMF leaves displayed stronger activities of superoxide dismutase, peroxidase and catalase, and higher content of glutathione and ratio of its reduced form to oxidized form, as compared with -AMF ones. Correspondingly, lesser oxidative damage was detected in +AMF than in -AMF plants, as indicated by the contents of H2O2 and malondialdehyde, electrolyte leakage, also by in situ visualization for the formation of H2O2, superoxide anion, and dead cells. The increased antioxidative capacity in +AMF plants was correlated with enhanced expression of antioxidation-related genes. Exposure to NO2 substantially impaired photosynthetic processes in both + AMF and -AMF plants, but an obvious mitigation was observed in the former than in the latter. For example, the total chlorophyll, net photosynthetic rate, stomatal conductance, and ribulose-1,5-bisphosphate carboxylase activity were 18%, 27%, 26%, and 40% higher, respectively, in +AMF than in -AMF plants under NO2 stress. The differential photosynthetic performance was also revealed by chlorophyll fluorescence imaging. We analyzed the expression patterns of some genes related to photosynthesis and carbon metabolisms, and found that all of them exclusively presented a higher expression level in +AMF plants relative to -AMF ones under NO2 stress. Taken together, this study provided evidence that AMF symbiosis played a positively regulatory role in host plant responses to NO2, probably by increasing leaf nitrate metabolism and antioxidative defense, and maintaining the photosynthetic efficiency to some extent, wherein the transcription regulation might be a main target.

Fibroblast growth factor 21 inhibited ischemic arrhythmias via targeting miR-143/EGR1 axis.

Ventricular arrhythmia is the most common cause of sudden cardiac death in patients with myocardial infarction (MI). Fibroblast growth factor 21 (FGF21) has been shown to play an important role in cardiovascular and metabolic diseases. However, the effects of FGF21 on ventricular arrhythmias following MI have not been addressed yet. The present study was conducted to investigate the pharmacological action of FGF21 on ventricular arrhythmias after MI. Adult male mice were administrated with or without recombinant human basic FGF21 (rhbFGF21), and the susceptibility to arrhythmias was assessed by programmed electrical stimulation and optical mapping techniques. Here, we found that rhbFGF21 administration reduced the occurrence of ventricular tachycardia (VT), improved epicardial conduction velocity and shorted action potential duration at 90% (APD90) in infarcted mouse hearts. Mechanistically, FGF21 may improve cardiac electrophysiological remodeling as characterized by the decrease of INa and IK1 current density in border zone of infarcted mouse hearts. Consistently, in vitro study also demonstrated that FGF21 may rescue oxidant stress-induced dysfunction of INa and IK1 currents in cultured ventricular myocytes. We further found that oxidant stress-induced down-regulation of early growth response protein 1 (EGR1) contributed to INa and IK1 reduction in post-infarcted hearts, and FGF21 may recruit EGR1 into the SCN5A and KCNJ2 promoter regions to up-regulate NaV1.5 and Kir2.1 expression at transcriptional level. Moreover, miR-143 was identified as upstream of EGR1 and mediated FGF21-induced EGR1 up-regulation in cardiomyocytes. Collectively, rhbFGF21 administration effectively suppressed ventricular arrhythmias in post-infarcted hearts by regulating miR-143-EGR1-NaV1.5/Kir2.1 axis, which provides novel therapeutic strategies for ischemic arrhythmias in clinics.